Merrill Lynch sells Rs 1.90-cr shares of Matrix Labs
Drug manufacturer Matrix Laboratories today said Merrill Lynch Capital Markets ESPANA has sold shares worth Rs 1.90 crore of the pharma company through an open market transaction.business Updated: Mar 17, 2009 16:25 IST
Drug manufacturer Matrix Laboratories on Tuesday said Merrill Lynch Capital Markets ESPANA has sold shares worth Rs 1.90 crore of the pharma company through an open market transaction.
Foreign fund house sold 2,15,810 shares worth Rs 1.90 crore, Matrix Laboratories said in a filing to the Bombay Stock Exchange.
Post selloff Merrill Lynch Capital Markets ESPANA now holds 3.43 per cent stake in Matrix Laboratories, the filing added.
Shares of Matrix Laboratories were trading at Rs 97.35, up 7.04 per cent on the BSE.
Geetanjali Trading pledges 12.43 pc stake in Asian Paints. Asian Paints on Tuesday said one of its promoters Geetanjali Trading & Investments has reduced its pledged percentage to 12.43 per cent in the paint company.
Geetanjali Trading & Investments has revoked 7.5 lakh shares on March 6, resulting in decrease in percentage of pledged shares to 12.43 per cent, from earlier 13.37 per cent.
After the aforesaid transaction, the total number of shares pledged by the promoters’ group companies has come down to 15.20 per cent from 15.42 per cent, the filing added.
Shares of Asian Paints were trading at Rs 740, up 1.91 per cent on the BSE.